Synairgen Plc

SNG:LN

Company Profile

Synairgen is a drug discovery and development company founded by University of Southampton Professors Stephen Holgate, Donna Davies and Ratko Djukanovic.

The business, focused primarily on severe asthma and COPD, uses its differentiating human biology BioBank platform and world-renowned international academic Key Opinion Leader network to discover and develop novel therapies for respiratory disease.

Classification

SectorHealthcare
IndustryNot yet available
SubindustryNot yet available

Financials

Financial data is not yet available for this company.

Financials Data

Financial data is not yet available for this company.